Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

Abstract

Platinum-based therapy remains as one of the standard options in advanced CSCC management. Agents to improve response rates are needed and future trials should address the use of novel targeted and new chemotherapy combinations in CSCC.